Poxel SAS Raises $17 Million to Progress Imeglimin Development to Treat Type 2 Diabetes
12/18/2012 6:36:52 AM
More...
|
New Clinical Results for an Anti-Diabetic Compound in Development at Poxel SAS
10/26/2011 8:58:53 AM
More...
|
Poxel SAS Raises EUR16 million (USD 19.7 Million) in a Series A Financing to Accelerate Pipeline Development
7/8/2010 7:25:07 AM
More...
|
Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
5/28/2009 11:22:48 AM
More...
|